Trulicity now indicated as adjunct to diet, exercise

eAwazMedicine

TORONTO – In recent past, Health Canada approved Trulicity® (dulaglutide) to reduce the risk of non-fatal stroke in adults with type 2 diabetes mellitus who have multiple cardiovascular risk factors or established cardiovascular disease, as an adjunct to diet, exercise, and standard of care therapy.  This decision makes Eli Lilly and Company’s Trulicity the first and only GLP1 receptor agonist (RA) approved …

Ontario Expanding Access to Hospital Care in Hamilton

eAwazHealth

HAMILTON — The Ontario government is connecting people in the Hamilton area to better, more modern specialized adult health care services by investing $10 million to support the redevelopment of Hamilton Health Sciences’ Juravinski Hospital. “Our government is making historic investments in Ontario’s health care system to expand access to care and make it faster and easier for people to connect to …